PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
Global First | NMPA Accepts IND Application for Mabwell's Innovative LILRB4/CD3 TCE Bispecific Antibody 6MW5311
2026-04-16T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Mabwell Announces Acceptance of Supplemental Biologics License Application by NMPA for MAIWEIJIAN (Denosumab)
2026-04-16T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Clicklinks | 14-Day Candidate Antibody Discovery - Sanyou AI-STAL 2.0 Defines the Era of Ultimate Speed in Drug Molecule Discovery
2026-04-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Tsingke Unveils 'Zero-Contact' Gene Synthesis to Safeguard Core Genetic Sequences
2026-04-15T    Biotechnology   Computer/Electronics   Health Care/Hospital   High Tech Security 
Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform
2026-04-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Taiho Ventures, LLC Celebrates 10th Anniversary
2026-04-15T    Banking/Financial Service   Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
RIMAN's Parent Company Announces Sponsored Research Agreement to Advance Araliadiol Using Organ-on-a-Chip Technology
2026-04-15T    Biotechnology   Cosmetics & Personal Care   Health Care/Hospital   Household/Consumer/Cosmetics 
WuXi Biologics Achieves ISO 13485 Certification, Signifying Strong Capabilities in Drug-Device Combination Product Development and Manufacturing
2026-04-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
SST001, an α-syn PET tracer from Mabwell's incubated company SynuSight Biotech, received NMPA approval to initiate a clinical trial
2026-04-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Advances in Parkinson's Disease Cell Therapy: XellSmart Launches a Multicenter Phase II Clinical Trial Following Encouraging Phase I Results
2026-04-14T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.